LeMaitre Vascular (LMAT) : Traders are getting increasingly bearish on LeMaitre Vascular (LMAT), as can be seen in the addition of short positions from 405,315 on Jul 29, 2016, to 407,382 on August 15, 2016. The net change in shorts is 2,067 shares, an increase of 0.5%. 4 days remain before the expiry. The 3% of outstanding short positions on the stock compared to its float, shows that traders expect the stock to fall from the current levels. The daily volume of the stock is 115,475. The short interest information was released on Wednesday Aug 24th after the market close.
LeMaitre Vascular (NASDAQ:LMAT): The stock opened at $17.50 on Wednesday but the bulls could not build on the opening and the stock topped out at $17.55 for the day. The stock traded down to $16.97 during the day, due to lack of any buying support eventually closed down at $17.07 with a loss of -1.90% for the day. The stock had closed at $17.40 on the previous day. The total traded volume was 81,836 shares.
In a related news,The director of Lemaitre Vascular Inc, Lemaitre Cornelia W sold 22,500 shares at $17.36 on August 16, 2016. The Insider selling transaction had a total value worth of $390,600. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop, manufacture and market medical devices and implants used primarily in the field of vascular surgery. The Companys product lines include valvulotomes, balloon catheters, carotid shunts, biologic patches, biologic grafts, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, angioscopes and powered phlebectomy devices. The Company develops, manufactures and markets vascular devices to address the needs of vascular surgeons. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.